Rexall Ready to use 4pk LAXATIVE
NDC 55910-999, SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM, enema, from Dolgencorp, LLC.
- Product NDC
- 55910-999
- Status
- Listed
- Labeler
- Dolgencorp, LLC
- Dosage form
- ENEMA
- Route
- RECTAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M007
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55910-999 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM7 g/118mL
- SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM19 g/118mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55910-999-06 | 55910099906 | 4 BOTTLE, PLASTIC in 1 CARTON (55910-999-06) / 133 mL in 1 BOTTLE, PLASTIC |
| 55910-999-12 | 55910099912 | 2 BOTTLE, PLASTIC in 1 CARTON (55910-999-12) / 133 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 55910-999 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55910-999 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55910-999. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.